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Abstract
Background: Abnormal Savda Munziq (ASMq) is a traditional prescription in Uyghur Medicine, and its treatment of
complex diseases such as tumors and asthma has been proven to be effective in Uyghur medical clinical practice.
The efficacy-enhancing and toxicity-reducing properties of ASMq were studied on mice with transplanted cervical
cancer (U27) tumors, which were treated with 5-fluorouracil (5-FU) in this work.
Methods: To investigate the synergistic effect of ASMq and 5-FU on U27 cells, inhibitory effects on cell proliferation
were determined through a MTT assay. 48 Kunming mice which were randomly divided in to 6 groups: control group,
model group, 5-FU group, 5-FU combine with ASMq low-dose group, 5-FU combine with ASMq medium-dose group,
and 5-FU combine with ASMq high- dose group, the inhibition rate of the tumor, the viscera indexes, and the content
of serum tumor necrosis factor-α (TNF-α), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were
determined. The expression levels of transforming growth factor-β1 (TGF-β1) and human papillomavirus type 16 E2
(HPV16 E2) protein were assessed by Western blot. Pathological changes in the liver were observed.
Result: The inhibition rates of tumors, the 5-FU + ASMq.H group(80.64%), 5-FU + ASMq.M group (90.67%), 5-FU + ASMq.L
group (72.03%) and 5-FU group (66.89%), clearly indicated that the effects of tumor inhibition. The thymus index and
spleen index were increased, and the serum concentration of TNF-α increased while ALT and AST concentrations were
decreased, and TNF-α protein expression were increased while TGF-β1 and HPV16 E2 were decreased. ASMq might can
improve livers central vein hyperemia and interstitial edema, and preserve the radial structure of the hepatic cords.
Conclusions: The results suggested that ASMq might reduce toxicity and enhance the efficacy of the chemotherapeutic
drug 5-fluorouracil in the treatment of cervical carcinoma.
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Background
Cervical cancer is the fourth most common malignancy
cancer among women allover the world. According to
the data from 2012, 528,000 cases of cervical cancer
were detected throughout the world annually, caused
266,000 deaths per year. 85% of these cervical cancer
cases occured in developing countries which is the top
cause of death in these countries [1, 2]. As a common
method used on comprehensive cancer treatment,
chemotherapy has made inspiring achievements. In
recent years, a new type of chemotherapy called neoad-
juvant chemotherapy has been proposed. However,
chemotherapy drugs that killing tumor cells may also
have side effects, such as reducing immune function and
increased organ toxicity. In addition, chemotherapy also
can cause the drug resistance of tumor. Recent studies
have shown that chemotherapy treated with traditional
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Chinese medicine could improve the efficiency of tumor
inhibition, while mitigating their side effects [3–5].
Abnormal Savda Munziq [6, 7] is made from 10 kinds
of medicinal herbs including Anchusa ita1ica Retiz,
Cordia dichotoma Forst, Ziziphus jujuba Mill, Foeniculum
vulgare Mill, Glycyrrhiza uralensis Fisch, Dracocephalum
moldavica L, Euphorbia humifusa Willd, and Adiantum
capillus-veneris L. Previous studies have shown that
ASMq can inhibit the growth of human cervical cancer
[8] and other cells, and inhibit the growth of mice trans-
planted s180 tumor [6, 7]. In addition, Asmq not only
has the reversal effect on 5-FU multidrug resistance cell
line Bel/Fu cells resistant [9], and low concentrations of
AMSq total phenolics(50 μg/mL) has no inhibitory effect
on HeLa cells, but also can enhance cisplatin and
docetaxel on HeLa cell growth inhibition rate [10].
In this study, a transplanted tumor-bearing mouse
model of cervical cancer was proposed and used to
investigate the efficacy enhancement and toxicity reduc-
tion of chemotherapy drug 5-fluorouracil (5-FU) by
Abnormal Savda Munziq. The results of this study




Abnormal Savda Munziq was purchased from Xinjiang
Qikanghabo Uighur medicine research co. Ltd. (Urumqi,
Xingjiang, China). 5-Fluorouracil was purchased from
Tianjin Jinyao Pharmaceutical Industries Co. Ltd.
(Tianjin, China). TNF-α was purchased from Boster
Biological technology (Wuhan, Hubei, China). AST and
ALT were purchased from Nanjing Jiancheng Biological
Technology (Nanjing, China). 3-(4, 5-dimethylthiazolyl-
2)-2,5-diphenyltetrazolium bromide (MTT) was pur-
chased from Beijing Cellchip Biotechnology Corporation
(Beijing, China).
Forty-eight Kunming mice with a body weight of
18-22 g (male and female) were provided by Xinjiang
Medical University Laboratory Animal Center (Certificate
No. SCXK (Xin) 2011–0004). A mouse strain of
cervical carcinoma (U27) was provided by the cell
bank of Wuhan University.
The Abnormal Savda Munziq preparation
The dried Lavandula angustifolia Mill and Foeniculum
vulgare Mill were extracted with 10 times water by
steam distillation to get the volatile oil, then collecting
the liquid after filtration. After mixing the volatile oil
and β-cyclodextrin, the inclusion were dried, grind and
filtered. The dried crude powder of Ziziphus jujuba Mill,
Anchusa italica Ret, Alhagi pseudalhagi (Bieb) Desv and
Cordia dichotoma G Forst were mixed and extracted
with 10 times water under reflux. After filtration
through filter paper, followed by concentration in vac-
uum and centrifugation, and the supernatant were
collected. The dried raw powder of Glycyrrhiza glabra L,
Euphorbia humifusa Willd Euphorbia maculata L,
Melissa officinalis L and Adiantum capillus-veneris L
were extracted with 10 times ethanol (65%), and the fil-
trate were collected after filtration. All the liquid of
water extracts were mixed and concentration in vacuum
to obtain the extractum with relative density of
1.20–1.25. After dried and grinded, the extractum were
mixed with the volatile oil and lactose. With PVP (5%, in
90% ethanol), added the mixture were knead and
through a 14 mesh sieve. The granules were obtained
after dried and granulated.
MTT assay for the inhibition of U27 cell growth
The U27 cells growing in logarithmic phase were seeded
in 96-well plates at 1.0 × 104 cells per well and allowed
to adhere overnight, after which a series of concentra-
tions of ASMq (1.25, 2.5, 5, 10, and 20 mg/mL) and/or
5-FU (3.125, 6.25, 12.5, 25 and 50 mg/L) were added to
the well for 24, 48 or 72 h. Controled experiments were
carried out by adding ethanol without ASMq to U27
cells. After 24, 48 or 72 h of incubation, 20 μL MTT
(5 mg/mL) was added to each well and the cells were
re-incubated for another 4 h at 37 °C. After removaling
of the supernatant gently, 200 μL of dimethyl sulfoxide
(DMSO) was added to each well to solubilize the purple
formazan crystals completely. Absorbance values at
570 nm were measured with a microplate reader and
were reported as a percentage of growth with respect to
the control. Inhibition rate of cell growth was measured
using the formula: inhibition rate (%) = [1- OD570
(experiment group)/OD570 (control group)] × 100. All
experiments were repeated in triplicate. The drug
concentration that produced 50% inhibition of cell
proliferation (IC50) was calculated and analyzed for
5-FU, ASMq and the combination.
Establishment of mouse model bearing U27 cell-induced
tumor and grouping
Kunming mice housed in groups of four and given five
days to acclimate to the housing facility. Environmental
conditions were a temperature of 20 ± 2 °C, humidity of
55 ± 5%, 12-h light and 12-h dark cycle with lights on at
08:00 and off at 20:00. Animals were housed in
290 × 178 × 160 mm cages and given ordinary food
and water. At the start of the experiments animals
weighed 20 ± 2 g.
Forty-eight Kunming mice were randomly divided into
the following groups: 1) control group, 2) model group,
3) 5-fluorouracil (5-FU) alone, 4) 5-fluorouracil
combined with a high dose of Abnormal Savda Munziq
(5-FU + ASMq.H) group, 5) 5-fluorouracil combined
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with a medium dose of Abnormal Savda Munziq
(5-FU + ASMq.M) group, and 6) 5-fluorouracil com-
bined with a low dose of Abnormal Savda Munziq group
(5-FU + ASMq.L) group. There were 8 mice in each
group, four male and four female. Except the control
group, the U27 cell-induced tumor model was estab-
lished in all mice in the other 5 groups. Methods:
healthy mice were selected from which to aspirate
ascites under aseptic conditions. U27 cells was diluted
into 1.0 × 107 cfu/mL using normal saline and added to
the ascites suspension. Then 0.2 mL of ascites suspen-
sion was subcutaneously inoculated into the axilla of the
left forelimb of every mouse. The entire process was
completed within 30 min. After 24 h, intervention was
performed according to the weight of mice: 1) control
group: intraperitoneal injection of normal saline (NS)
0.2 mL/10 g once every other day, and intragastric
administration of NS 0.2 mL/10 g once every day; 2)
model group: intraperitoneal injection of NS 0.2 mL/10 g
once every other day, and intragastric administration of
NS 0.2 mL/10 g once every day; 3) 5-FU group: intraperi-
toneal injection of 5-FU 30 mg/kg once every other day,
and intragastric administration of NS 0.2 ml/10 g once
every day; 4) 5-FU + ASMq.L group, 5) 5-FU + ASMq.M
group and 6) 5-FU + ASMq.H group: intraperitoneal
injection of NS 0.2 mL/10 g once every other day,
and intragastric administration of Abnormal Savda
Munziq 2 g/kg, 4 g/kg and 8 g/kg, respectively, once
every day for 10 days.
Expression levels of TNF-α, ALT and AST in mouse serum
After continuous treatment for 10 days, orbital blood
was collected and kept at room temperature for 30 min,
then centrifuged at 3000 rpm for 20 min before the
supernatants were collected. The expression levels of
TNF-α, ALT and AST in mouse serum were determined
according to the protocols of the corresponding kit.
Determination of viscera weight, viscera index and
inhibition rate of tumor
The length (A) and the shortest(B) diameter of the
tumor were measured once every three days, and the
tumor volume was calculated according to the formula
V = AB [2]/2. The tumor growth curve was according to
each group of tumor-bearing nude mice. After continu-
ous treatment for 10 days, the mice were terminated.
The thymus, spleen, liver and kidneys were immediately
separated. The surrounding connective tissue and fat
were excluded. The organs were dried of surface
moisture using filter paper, and weighed. Viscera
indexes for the thymus, spleen, liver and kidney were
calculated by the following formula: organ index = organ
weight (mg)/body weight (g). The inhibition rate for
each group was obtained using the following formula:
inhibition rate of tumor = (average tumor weight in
model group - average tumor weight in experimental
group)/average tumor weight in model group.
Analysis of HPV16 E2 and TGF-β1 protein expression in
tumors by western blot
Denaturation of protein samples and gel electrophoresis.
A 10% separation gel (4 mL) and a 4% stacking gel
were prepared for gel electrophoresis. The frozen
protein samples were thawed on ice immediately prior
to use. The protein content was quantified using and the
appropriate volume of protein sample was mixed with
5× sample buffer, denatured at 95 °C for 10 min, and
loaded onto the gel. The electrophoresis apparatus was
set to constant voltage of 80 V to allow the samples to
run from stacking gel to separating gel at a rate of about
8 V/cm. Then the voltage was increased to 120 V.
Gel transfer membrane and detection.
The polyvinylidene fluoride(PVDF) membrane was
immersed in 100% methanol for 2-3 min, The water
cleaned membrane rinsed with transfer buffer twice for
2 min and then soaked in transfer buffer. Six layers of
filter paper were cut to the same dimensions as the gel
and soaked in transfer buffer. The gel containing the
samples was washed once with transfer buffer, then the
transfer membrane was placed in blocking buffer at
room temperature and incubated for 1 h. The primary
antibody was diluted with blocking buffer and incubated
with the membrane overnight at 4 °C. The reacting
membrane was put into a dish and washed three times
with Tris Buffered Saline with Tween(TBST) for 10 min,
then incubated with secondary antibody by shaking for
1 h at room temperature. The membrane was then
washed in TBST to remove the free secondary antibody,
exposed, developed and fixed in the darkroom. Relative
expression levels were calculated using GAPDH as a
reference protein. The experiment was repeated 3 times,
and the mean expression was calculated.
HE staining of liver in mice bearing U27 cell-induced
tumors
Preparation of liver sections
The liver samples were fixed in 10% formaldehyde
and immersed in 70% ethanol for 3 h, 80% ethanol
for 2 h, 90% ethanol for 1.5 h, 95% ethanol for 2 h,
100% ethanol for 1 h, successively, then incubated in
xylene for 30 min, and embedded in melted paraffin
for 3 h until solidification to a wax block at room
temperature. Then the paraffin embedded tissue was
sectioned with 4 μm thick.
Normal HE staining
Paraffin was removed from the sections by soaking them
in xylene. They sections were then rehydrated using
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graded ethanol, then washed with distilled water, and
stained with hematoxylin. Hydrochloric acid (1%)
containing ethanol was used for differentiation, then
samples were rinsed with weakly alkaline water before
staining with Eosin. After dehydrated through graded
ethanol, the sample were placed in xylene and covered
by resin. The morphological changes in the liver cells
were then observed using a microscope.
Statistical analysis
The results were analyzed by SPSS17.0. Normality test
and homogeneity test were performed for all the data.
The results were represented by mean ± standard
deviation (−x ± s) and analyzed by a one-way analysis of
variance and chi-square test. Analysis of variance was
used for comparisons between groups, and P<0.05 was
considered statistically significant.
The combination of the two drugs and the efficacy of
the judgment according to the Chou-Talalay joint index
method of the dose effect formula calculated the two
drugs combined in a variety of effects of the index.
When combination index is 1, the effect between ASMq
and 5-FU is considered additive; when combination
index is significantly greater than or less than 1, the
effect is considered subadditive or supraadditive,
respectively. CI = (D1/DX1) + (D2/DX2), where D1 and
D2 are the inhibition rate of ASMq and 5-FU alone on
U27 cell growth, Dx1 and Dx2 are the inhibition rate of
ASMq and 5-FU in combination on U27 cell growth.
Results
Effects of ASMq and 5-FU on the proliferation of U27 cells
To investigate the synergistic effect of ASMq and 5-FU
on U27 cells, inhibitory effects on cell proliferation were
determined through a MTT assay. First, growth inhib-
ition was measured in U27 cells treated with each of the
two compounds individually. The results demonstrated
that ASMq and 5-FU could markedly inhibit the prolif-
eration of U27 cells in a significant time- and dose-de-
pendent manner (Fig. 1). In these tests, the ASMq or 5-
FU administered for various durations of time had IC50
values of 52.45 mg/mL (ASMq: 24 h), 36.78 mg/mL
(ASMq: 48 h), 21.12 mg/mL (ASMq: 72 h), 110.12 mg/L
(5-FU: 24 h), 81.42 mg/L (5-FU: 48 h) and 35.42 mg/L
(5-FU: 72 h). When the two compounds were used in
combination, the IC50 values for ASMq fell to 18.13 mg/
mL, 12.34 mg/mL, and 6.24 mg/mL for incubations of
24, 48 and 72 h, respectively. As the data in Fig. 1 re-
flect, ASMq can notably strengthen the inhibitory effect
of 5-FU on the growth of U27. The IC50 values for 5-FU
in the presence of ASMq sharply dropped, reaching
46.03 mg/mL, 26.73 mg/mL and 14.21 mg/mL after 24,
48 and 72 h, respectively. An evaluation of the inter-
action between ASMq and 5-FU and its effect on U27 cell
growth (Table 1) yielded a combination index (CI) <1 for
different time points (24 h, 48 h and 72 h), suggesting a
synergistic effect between the two drugs.
Mice daily activities
We observed mice behaviour, autonomic activities,
ingestion, drinking, hairs, faeces and urine daily. There
was no secretion in eyes, ears, nose and mouth.
The effects of 5-FU combined with Abnormal Savda
Munziq on the viscera index and the inhibition rate of
tumors in mice bearing U27 cell-induced tumors
Comparing with the control group, the thymus index
and spleen index of mice in the model group, the 5-FU
group, 5-FU + ASMq.H group and 5-FU + ASMq.L
group decreased significantly (P < 0.05); the liver index
of mice in the 5-FU group and different doses groups of
5-FU + ASMq were increased significantly (P < 0.05);
the kidney index of mice in the different does groups of
5-FU + ASMq were decreased significantly (P < 0.05).
Comparing with the model group, the thymus and spleen
index of mice in the 5-FU group, 5-FU + ASMq.H group
and 5-FU + ASMq.L group were decreased significantly
(P < 0.05); the thymus index and spleen index of mice in
the 5-FU + ASMq.M group increased significantly
(P < 0.05); the liver index in mice in the 5-FU group,
5-FU + ASMq.H group and 5-FU + ASMq.L group were
increased significantly (P < 0.05); the kidney index in the
5-FU group was increased significantly (P < 0.05); the
kidney index in the 5-FU + ASMq.H group was decreased
significantly (P < 0.05). Comparing with the 5-FU group,
the thymus index and spleen index of mice different doses
groups of 5-FU + ASMq were increased significantly
(P < 0.05); the liver index and kidney index of mice in
different doses groups of 5-FU + ASMq were decreased
significantly (P < 0.05). These results were summarized
and shown in Table 2.
Table 3 shows that the inhibition rate of tumors in
mice in the 5-FU + ASMq.H group(80.64%), 5-
FU + ASMq.M group(90.67%), 5-FU + ASMq.L
group(72.03%) and 5-FU group(66.89%), which clearly
indicated that the effects of tumor inhibition. Comparing
with the model group, the tumor weight in mice in the
5-FU group and groups of 5-FU + ASMq at different
doses, decreased significantly (P < 0.05). Comparing with
the 5-FU group, the tumor weight in mice in the 5-
FU + ASMq.H group and 5-FU + ASMq.M group were
decreased significantly (P < 0.05).
As shown in Fig. 2, after treated with ASMq and 5-FU,
the mean average tumor volume was smaller than the
group which treated only with 5-FU, and the difference
was statistically significant (P < 0.05).
Yang et al. BMC Complementary and Alternative Medicine  (2017) 17:201 Page 4 of 10
The effects of 5-FU combined with Abnormal Savda
Munziq on the expression of ALT, AST and TNF-α in serum
Comparing with the control group, the TNF-α expres-
sion in mice serum in the model group and 5-FU group
were decreased significantly (P < 0.05); TNF-α expres-
sion in mice in the 5-FU + ASMq.H group and 5-
FU + ASMq.M group were increased significantly
(P < 0.05); the expression of ALT and AST in mice in
the 5-FU group and different doses groups of 5-
FU + ASMq were increased significantly (P < 0.05).
Comparing with the model group, TNF-α expression in
mice in the 5-FU group was decreased significantly
(P < 0.05); TNF-α expression in mice in different doses
Fig. 1 Inhibitory effect of ASMq or/and 5-fluorouracil on the growth of U27 cells. a Growth inhibition rate of U27 cells following 24, 48 or 72 h
treatment with increasing concentrations of 5-fluorouracil. b Growth inhibition rate of U27 cells following 24, 48 or 72 h treatment with increasing
concentrations of Abnormal Savda Munziq (ASMq). c Growth inhibition rate of U27 cells following 24, 48 or 72 h treatment with increasing
concentrations of 5-fluorouracil combined with Abnormal Savda Munziq (ASMq)
Table 1 Analysis of the interaction between the inhibition effect
of ASMq in combination with 5-fluorouracil on cell growth by
combination index
Times(h) Combination index P value
24 0.7131 ± 0.1072 <0.05
48 0.6071 ± 0.1021 <0.05
72 0.5321 ± 0.0971 <0.05
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groups of 5-FU + ASMq were increased significantly
(P < 0.05); the content of ALT and AST in mice in the
5-FU group and different doses groups of 5-FU + ASMq
were increased significantly (P < 0.05). Comparing with
the 5-FU group, TNF-α expression in mice in different
doses groups of 5-FU + ASMq were increased signifi-
cantly (P < 0.05); the expression of ALT and AST in
mice in different doses groups of 5-FU + ASMq were
decreased significantly (P < 0.05). These results were
summarized shown in Table 4.
The effects of 5-FU combined with Abnormal Savda
Munziq on the protein expression of HPV16 E2 and
TGF-β1 in mice bearing U27 cell-induced tumors
Compared with the model group, the level of protein
expression of HPV16 E2 and TGF-β1 in tumors in the
5-FU group and different doses groups of 5-FU + ASMq
were decreased significantly (P < 0.05). Compared with
the 5-FU group, the protein level of HPV16 E2 and
TGF-β1 in tumors in different doses groups of 5-
FU + ASMq were also decreased significantly (P < 0.05).
These results were shown in Fig. 3, Fig. 4 and Table 5,
respectively.
Results of pathological analysis
The pathological changes in the liver from all experi-
mental groups were analyzed by HE staining. From the
histological sections in Fig. 5. In the control group, the
liver tissue structure was normal, and no pathological
changes were found under low power lens or high power
lens. In the model group, the liver tissue structure was
not distinguished under low power lens, and the liver
cells generally swelling to be granular or eosinophilic
change. According to high power lens, the liver structure
was not distinguishable, and the liver cells generally
swollen and changed into granules. In the 5-FU group,
the liver tissue structure was not distinguishable, and the
cells were generally swollen and changed into granules,
or had diffuse eosinophilic change, and the central vein
was dilated. Under high power lens, the structure of liver
cells was not distinguishable, and the cells were generally
swollen and changed into granules, or having diffuse
eosinophilic change. In the 5-FU + ASMq.H group,
under low power lens, the structure of liver cells was not
distinguished, and the cells were generally swollen and
changed into granules, or having diffuse eosinophilic
change. Under the high power lens, the structure of liver
cells was not distinguishable, and the cells were generally
swollen and changed into granules. In the 5-
FU + ASMq.M group, under low power lens, the liver
tissue structure was normal, and the liver cells showed
slightly swollen and changed into granules, or diffuse
eosinophilic change. Under high power lens, swelling of
the liver cells showed granular degeneration or scattered
eosinophilic degeneration, and liver sinus were not dis-
tinguished. In the 5-FU + ASMq.L group, under the low
Table 2 The effects of 5-FU combined with Abnormal Savda Munziq on the viscera index in mice bearing U27 cell-induced
tumors (x±s)
Groups Dosage g/kg N Thymus index (mg/g) Spleen index (mg/g) Liver index (mg/g) Kidney index (mg/g)
Control - 8 3.965±0.123 5.864±1.989 467.457±189.841 14.4509±4.473
Model - 8 3.502±0.163ac 5.033±2.624ac 492.436±364.409c 13.913±3.880ac
5-FU 0.03 8 2.469±0.140ab 3.212±1.103ab 637.620±471.837ab 14.384±5.538b
5-FU+ASMq.H 8 8 3.174±0.087abc 4.256±1.928abc 547.370±186.089abc 12.637±3.249abc
5-FU+ASMq.M 4 4 8 3.862±0.088bc 5.699±1.435bc 504.413±109.636ac 13.981±2.884ac
5-FU+ASMq.L 2 8 3.112±0.161abc 4.148±1.872abc 519.447±244.387abc 13.960±5.482ac
VS control group,aP<0.05;VS model group, bP<0.05。VS 5-FU group, cP<0.05
Table 3 Inhibitory effect of Abnormal Savda Munziq on the growth of transplanted cervical cancer tumors in mice when combined
with 5-FU (x±s)
Groups Dosage/(g/kg) Start animals/End animals Weight/(mg) Tumor control rate/%
Control - 8/8 0.000±0.000 -
Model - 8/8 2596.45±293.296b -
5-FU 0.03 8/8 859.74±279.018a 66.89
5-FU+ASMq.H 8 8/8 502.57±327.528ab 80.64
5-FU+ASMq.M 4 8/8 242.31±154.845ab 90.67
5-FU+ASMq.L 2 8/8 726.31±514.482a 72.03
VS model group, aP<0.05;VS 5-FU group, bP<0.05
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power lens, the liver tissue structure was not distin-
guished, and the cells generally swelled and became
granular or scattered eosinophilic change, and focal
necrosis were found. Under the low power microscope,
the liver structure is not clear, cell swelling or granular
scattered eosinophilic degeneration, and liver sinus were
not distinguishable.
Discussion
Traditional Uyghur medicine shares the same origin of
Greco-Arab medicine. According to traditional Uyghur
medicine, nearly all diseases are caused by abnormal Hilits
(syndromes), which result from imbalanced dynamic
homeostasis of normal Hilits (humors): Kan, Phlegm,
Safra, and Savda [11]. With this theory, abnormal Savda
(syndrome) is predominant and is always the final
condition of other abnormal Hilits. abnormal Savda is
frequently associated with chronic and complex diseases,
e.g. type II diabetes, cardiovascular disease, asthma, malig-
nant tumors, and depression, particularly at advanced
stages [12].Uyghur medicine is an important part of
Chinese medicine, which provides unique approaches for
the treatment of cancers and other complex diseases. A
typical example is the Abnormal Savda Munziq [13],
which is widely used as a cancer treatment or chemother-
apy adjuvant in Uyghur clinical applications.
With consideration the compatibility of Chinese trad-
itional medicine with other medicines, an innovative
approach was used to combine western and Uyghur
medicines to achieve the goal of reducing toxicity while
maximizing efficacy. 5-FU is an anti-pyrimidine anti-
metabolite that is widely used in a variety of tumor
chemotherapies. However, clinical use has revealed a
major issue: the drug can cause strong immune inhib-
ition and even liver damage. Therefore, reducing the side
effects of chemotherapy and improving patients’ health
conditions have become critical to the treatment of
tumors. The results of this study suggested that the tumor
inhibition rate of 5-FU combined with a high or medium
dosage of Abnormal Savda Munziq is higher tha than
which used alone, indicated that Abnormal Savda Munziq
can enhance the anti-tumor effects of 5-FU.
TNF-α is a pleiotropic cytokine produced by the acti-
vation of macrophages and monocytes. It has a highly
selective cell killing function, which can kill cancer cells
while has no risk of damage to normal cells [14, 15].
TNF-α can directly kill tumor cells by activating T
lymphocytes and stimulating the human body toproduce
cytokines and antibodies. It also induces tumor cell
apoptosis by acting on vascular endothelial cells [16].
TGF-β1 [17–19] is acytokine that is produced by many
types of cells such as lymphocytes and monocytes, which
is known to inhibit cytokine production. It can also
inhibit the production of IFN-γ and TNF-α from periph-
eral blood mononuclear cells (PBMC). The results of
this study suggested that TNF-α content in the serum
was at a low level, while the protein expression of
TGF-β1 in tumor tissue was at a high level in our tumor
model group. With the combination of 5-FU and Abnor-
mal Savda Munziq, the level of TNF-α is elevated in the
Fig. 2 Tumor growth curve
Table 4 The effects of 5-FU combined with Abnormal Savda
Munziq on the expression of ALT, AST and TNF-α in mice
serum (x±s)
Groups TNF-α(pg/ml) ALT(pg/ml) AST(pg/ml)
Control 17.874±1.561 84.800±1.063 48.500±0.509
Model 15.837±0.981ac 80.400±4.014c 48.280±0.621c
5-FU 14.630±1.120ab 517.925±23.055ab 240.165±6.725ab
5-FU+ASMq.H 21.718±0.991abc 208.260±15.423abc 153.370±0.985abc
5-FU+ASMq.M 26.906±0.654abc 130.175±15.066abc 79.610±1.053abc
5-FU+ASMq.L 18.520±1.223bc 409.995±46.607abc 207.075±9.730abc
VS control group, aP<0.05;VS model group, bP<0.05 VS 5-FU group, cP<0.05
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serum, while the TGF-β1 expression is reduced. This
suggested that Abnormal Savda Munziq may diminish
the inhibiting effect of TGF-β1 on IFN-γ and TNF-α in
PBMC, thereby increasing the concentration of TNF-α
and enhancing anti-tumor effects [20, 21].
As the main regulatory protein of HPV DNA replica-
tion and gene expression, high-risk HPV E2 protein can
repress cell mitosis and, therefore, cause metaphase-
specific apoptosis. This process occurs regardless of
oncogenes E6 and E7. Cells with high-risk HPV E2
protein expression often show polyploidy, abnormal
chromosomal separation, centrosome amplification and
increasing instability of the cell genome. HPV-encoded
E2 protein may induce the integration of virus DNA and
the human genome when combined with host HPV
infection cytokines. This will effectively promote the
integration of the virus and the host genome, which
plays an important role in the oncogenic potential of
high-risk HPV [22].
Immune function is closely related to the development
of tumors, and cancer patients often experience immune
dysfunction. This low immune function is more obvious
in patients undergoing chemotherapy. The experimental
results show that 5-FU damaged the body’s immune or-
gans by suppressing tumors, and reducing the spleen
and thymus indices. After applying different doses of
Abnormal Savda Munziq in combinated with 5-FU, the
spleen and thymus indices were significantly increased,
which indicated that Abnormal Savda Munziq could
reduce the damage of chemotherapy drugs to immune
organs and protect the body’s immune system to a
certain extent.
AST and ALT are mainly distributed in liver cells. ALT
expression is a sensitive indicator of liver damage, when
clinically meaningful increased enzyme activity is ob-
served in the cytoplasm. AST, which occurs mostly in
the mitochondria but can also sometimes also be
found in the cytoplasm, can reflects the cardiac function
Fig. 3 The effects of 5-FU combined with Abnormal Savda Munziq on the protein expression of HPV16 E2 in mice bearing U27 cell-induced tumors
Fig. 4 The effects of 5-FU combined with Abnormal Savda Munziq on the protein expression of TGF-β1 in mice bearing U27 cell-induced tumors
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index. An elevated ALT index indicates more liver cell
damage and enhanced membrane permeability, while an
elevated AST index suggests mitochondrial damage. The
results showed that, after using 5-FU, AST and ALT levels
in serum were significantly increasing, with combined
treatment with Abnormal Savda Munziq, the two indexes
were significantly decreasing. This suggested that Abnor-
mal Savda Munziq may potentially protect the liver and
heart during chemotherapy treatment. In addition, liver
biopsy results showed that liver damage was significantly
reducing after treatment combined with Abnormal Savda
Munziq, which further suggested that Abnormal Savda
Munziq had a protective effect on the liver.
Conclusions
In summary, when the chemotherapy drug 5-FU was
used combined with Abnormal Savda Munziq, its tumor
inhibition efficacy was enhanced while the damage of
the liver and immune organs was reduced. Therefore,
treatment efficacy of 5-FU combined with abnormal
savda munziq is increased and toxicity is reduced.
Abbreviations
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